Marché des médicaments contre le ptérygion au Moyen-Orient et en Afrique – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et perspectives du marché

Le ptérygion est une lésion fréquente de la surface oculaire qui débute dans la conjonctive limbique, au sein de la fente palpébrale, et progresse vers la cornée. Son nom vient du mot grec pterygos, qui signifie « aile ». La lésion apparaît plus fréquemment au niveau du limbe nasal que du limbe temporal, avec une apparence caractéristique en forme d'aile. L'exposition aux UV est fortement liée à l'apparition de ptérygions. Les personnes ayant des antécédents d'exposition élevée aux UV et celles vivant plus près de l'équateur ont une incidence plus élevée (travail en extérieur). Selon certaines recherches, les hommes ont une incidence légèrement plus élevée que les femmes, ce qui pourrait être dû à un taux d'exposition aux UV plus élevé.

Elle peut provoquer des rougeurs, une inflammation et un changement de l'aspect de l'œil. Elle peut également provoquer un astigmatisme, qui peut entraîner une vision floue. Elle peut également provoquer une excroissance blanchâtre ou rosâtre recouvrant le devant de l'œil. Elle peut toucher un œil ou les deux.

Le ptérygion est diagnostiqué à l’aide d’un microscope pour examiner les composants antérieurs de l’œil lors d’un examen oculaire complet et en fonction de l’apparence de la croissance tissulaire sur la cornée de la zone blanche de l’œil.

Data Bridge Market Research analyse que le marché des médicaments contre le ptérygion au Moyen-Orient et en Afrique connaîtra un TCAC de 3,5 % au cours de la période de prévision de 2022 à 2029.

Market Definition

Pterygium is a common ocular surface lesion that begins in the limbal conjunctiva within the palpebral fissure and progresses to the cornea. It is named after the Greek word pterygos, which means "wing".  The lesion occurs more frequently at the nasal limbus than the temporal with a characteristic wing-like appearance.  UV exposure is strongly linked to the occurrence of pterygia. Individuals having a history of elevated UV exposure and those living closer to the equator have a higher incidence (outdoor work). According to certain research, males have a somewhat higher incidence than females, which could simply be due to a higher rate of UV exposure.

Pterygium is diagnosed using a microscope to examine the front components of the eye during a full eye examination and based on the appearance of tissue growth on the cornea from the white area of the eye.

Middle East and Africa Pterygium Drug Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

• The rise in incidences and prevalences of ophthalmic disorders

According to data published in the National Library of Medicine (National Center for Biotechnology Information) in 2021, the prevalence rates vary in different places. It is most abundant in Cameron's "pterygium belt," which runs between 37° north and south of the equator.

The most common causes of pterygium include long-term exposure to ultraviolet (UV) light from the sun (most common cause) and eye irritation caused by hot, dry weather, wind, and dust. The affirmative factors state that this is the major driver for the global pterygium drugs market.

• The rise in the geriatric population

With the growing geriatric population across the globe, the prevalence of ophthalmic diseases with severe ocular pain is also growing. According to a data provided published in "Global Prevalence of Blindness and Distance and Near Vision Impairment in 2020: progress towards the Vision 2020 targets and what the future holds" by "The Association for Research in Vision and Ophthalmology" (ARVO) estimated 41.9 million people were blind.

With the growing population, the pressure on the healthcare system is increasing. The demand for care and services is rising to treat the problem of Ophthalmol disorder, including pterygium. Therefore, the increasing geriatric population is a great opportunity for the Middle East and Africa pterygium drug market.

Opportunity

• Programs and initiatives to reduce the burden of eye diseases

The International agency to prevent blindness has launched several programs and initiatives with well-reputed NGOs and corporates to spread awareness and reduce the burden of eye diseases.

For instance,

• International Agency endorses our Children's Vision and an initiative co-founded by the Brien Holden Vision Institute and the Vision For Life fund (created by Essilor) for the Prevention of Blindness (IAPB)

Restraint/Challenge

The growing prevalence of various ophthalmic disorders has also increased the necessity for timely treatments. However, the treatments and proper medication for ophthalmology disorders are not very cheap. Recent studies show that the price of topical steroids price is increasing in the past few years. Even though some topical ophthalmic steroids like prednisolone are mildly cheap, other advanced medications and eye drops are still expensive.

Middle East and Africa pterygium drug market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pterygium drug market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed market decision to achieve market growth.

Patient Epidemiology Analysis

The prevalence of ophthalmic disorders keeps showing a surge in growth due to the rise in chemical industries and pollution worldwide. Chemical burns and flash burns cause significant and severe ocular pain due to irritations over the eye surface.

According to data published in the National Library of Medicine (National Center for Biotechnology Information) in 2021, the prevalence rates vary in different places. It is most abundant in Cameron's "pterygium belt," which runs between 37° north and south of the equator. Pterygium prevalence has been reported to range from 0.3 to 29% worldwide.

Middle East and Africa pterygium drug market also provides detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, and adherence are some data variables available in the report. Direct or indirect impact analysis of epidemiology to the market growth are analyzed to create a more robust and cohot multivariate statistical model for forecasting the market in the growth period.

Post COVID-19 Impact on Middle East and Africa Pterygium Drug Market

COVID-19 has negatively affected the market. Lockdowns and isolations during pandemics complicate disease management and medication adherence. The lack of access to healthcare facilities for routine treatment and medication administration will further impact the market.

Recent Development

• In May 2022, Alcon announced the acquisition of EYSUVIS (loteprednol etabonate suspension) pharmaceutical eye drop from Kala Pharmaceuticals, Inc. The acquisition will complement the company's Systane family of eye drops, including preservative-free formulations.

Middle East and Africa Pterygium Drug Market Scope

Middle East and Africa pterygium drug market is categorized into eight notable segments based on disease type, stages, treatment, formulation, mode of purchase, population type, end-user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disease Type

• Progressive Pterygium
• Atrophic Pterygium

Based on disease, the Middle East and Africa pterygium drug market is segmented into progressive pterygium and atrophic pterygium.

Stages

• Stage 1
• Stage 2
• Stage 3
• Stage 4

Based on stages, the Middle East and Africa pterygium drug market is segmented into stage 1, stage 2, stage 3, and stage 4.

Treatment

• Artificial Tears/Topical Lubricants
• Steroid Eye Drops

Based on treatment, the Middle East and Africa pterygium drug market is segmented into artificial tears/topical lubricants, and steroid eye drops.

Formulation

• Eye Drops
• Eye Ointments
• Others

Based on formulation, the Middle East and Africa pterygium drug market is segmented into eye drops, eye ointments, and others.

Mode of Purchase

• Prescription
• Over the Counter (OTC)

Based on mode of purchase, the Middle East and Africa pterygium drug market is segmented into prescription and over-the-counter (OTC).

Population Type

• Geriatric
• Adults

Based on population type, the Middle East and Africa pterygium drug market is segmented into geriatric and adults.

End-User

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

Based on end-user, the Middle East and Africa pterygium drug market is segmented into hospitals, specialty clinics, home healthcare, and others.

Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Others

Based on distribution channels, the Middle East and Africa pterygium drug market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies.

Middle East and Africa Pterygium Drug Market Regional Analysis/Insights

Middle East and Africa pterygium drug market is analyzed, and market size insights and trends are provided by country, disease type, stages, treatment, formulation, mode of purchase, population type, end-user, and distribution channel. as referenced above.

The countries covered in the Middle East and Africa Middle East and Africa pterygium drug market report are South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait and Rest of Middle East and Africa.

Middle East and African  pterygium drug market are expected to grow due to increased government initiatives to reduce the burden of eye illnesses.

South Africa is expected to dominate the Middle East and Africa pterygium drug market in terms of market share and market revenue. It will continue to flourish its dominance during the forecast period. This is due to the increasing awareness of early diagnosis and treatment of disease

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Middle East and Africa Pterygium Drug Market Share Analysis

Middle East and Africa pterygium drug market competitive landscape provides details of the competitor. Details include company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, European presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the pterygium drug market.

Some of the major players operating in the Middle East and Africa pterygium drug market are Johnson & Johnson Services, Inc., Novartis AG, Akorn Operating Company LLC, Bausch & Lomb Incorporated, AbbVie Inc., Prestige Consumer Healthcare Inc., Théa Laboratories,  Wellona Pharma, Bayer AG, Zydus Group, Amneal Pharmaceuticals LLC,  OASIS Medical, Alcon, and Santen Pharmaceutical Co., Ltd. among others.

Research Methodology

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. Les données du marché sont analysées et estimées à l'aide de modèles statistiques et cohérents du marché. En outre, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. La principale méthodologie de recherche utilisée par l'équipe de recherche DBMR est la triangulation des données, qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). En dehors de cela, les modèles de données comprennent les grilles de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, les grilles de positionnement des entreprises, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse MEA vs régionale et la part des fournisseurs. Veuillez demander un appel d'analyste en cas de demande de renseignements supplémentaires.

SKU-68695